Investing in Growth: Oak HC/FT backs Infusion for Health, FTV brings Vagaro's valuation to $1bn Good morning!
There appears to be a big growth opportunity in infusion therapy as this pocket of healthcare increasingly draws growth-oriented investors that see room to redefine the category. In the latest such example, Oak HC/FT is investing behind a Los Angeles-based ambulatory infusion network called Infusion for Health with the aim of standing up its bigger vision around chronic disease management. “The fact that the [ambulatory infusion] market is so nascent and fairly unsophisticated is driving savvy investors to say there’s a first-mover advantage to secure,” Infusion for Health CEO Dan McCarty told PE Hub. Read it here.
In other big growth bets this morning, FTV Capital backed Vagaro, pushing its valuation to $1 billion. Vagaro, a cloud-based business management platform for beauty, fitness and wellness businesses, will use the funding to continue to develop its tools for businesses to book appointments, manage inventory, collect rent, run payroll and more. Read more on PE Hub.
Comms: If you’ve been following my recent coverage, you're well aware there's been a flurry of medical communications agencies drawing private equity backing. Another firm to put on your radar is Arsenal Capital, which is building out what it calls its Value Demonstration organization. This morning the PE firm said it acquired Guidemark Health, a healthcare marketing communications, training, and medical education agency with a focus on oncology and rare diseases. Read PE Hub's brief on the deal.
That’s it for me! Have a great week ahead, and as always, write to me at [email protected] with any tips, gossip or feedback.
Read the full wire commentary on PE Hub...
Also of note (may require subscriptions) Secondaries: One of the largest secondaries shops in the world is to be sold, bringing an end to fevered speculation around its future. Lexington Partners is being acquired by Franklin Templeton, bolstering the financial services holding company’s alternatives capabilities at a time of increasing investor appetite, it said in a statement. Read more on Buyouts.
Credit: As part of record credit fundraising in the third quarter, Carlyle Group effectively met the $3.5 billion target it set for a second opportunistic offering. The private equity giant recently filed Form D fundraising documents showing Carlyle Credit Opportunities Fund II and a parallel pool raised nearly $3.46 billion. Read more on Buyouts. En route: Landmark Partners has held a first close on its 17th private equity secondaries fund. The Ares Management-owned firm has collected $799.35 million for Landmark Equity Partners XVII, according to filings with the US Securities and Exchange Commission. Read it on Secondaries Investor.
They said it “There’s no other market where trillions of dollars of spend are going to be fundamentally rethought, re-evaluated and redefined over the coming 15 or 20 years.” Ezra Perlman, co-president at Francisco Partners, speaks to PE Hub about healthcare investment activity and the exuberance around value-based care.
Today's letter was prepared by Sarah Pringle Subscribe now to get full, unlimited access to all PE Hub content, including every PE Hub Wire article. Please visit Buyouts for the latest insight into LP activity and Venture Capital Journal for comprehensive coverage and analysis of what’s happening in VC. To update your PE Hub email preferences, or to unsubscribe, click here. |